Filter by
Date
Cancer type
Cancer stage
Biomarker
Method of analysis
Selected categories
December 2024
SABCS: A novel, semi-automated Pipeline for HER2 Quantification on CTCs in breast cancer patients. Is cytopathology of peripheral blood a new diagnostic option?
AACR LBx 24 – Development of a scoring system to classify HER2 protein expression in Circulating Tumour Cells through immunofluorescence following isolation using Parsortix® instruments
ANGLE Europe Limited, Guildford, UK, Published at the AACR LBx Conference 2024
AACR LBx 24 – Investigating PD-L1 status in Circulating Tumour Cells isolated from the blood samples of lung cancer patients
EACR LBx 24 – Enhancing Multiplexing Capabilities in Digital PCR for Circulating Tumour Cell Analysis Using Amplitude-Based Methodology
ANGLE Europe Limited, Guildford, UK, Published at the EACR LBx Conference 2024
EACR LBx 24 – Combined epitope-independent microfluidic isolation and advanced staining of circulating tumour cells isolated from metastatic prostate cancer blood samples.
ANGLE Europe Limited, Guildford, UK, Published at the EACR LBx Conference 2024
September 2024
DDR Conference – Detection of DNA Damage Response Biomarkers in Circulating Tumour Cells using ANGLE’s Parsortix® instrument and downstream immunofluorescence assays
In this proof of concept study, we aimed to assess the performance of ANGLE's IF assays for the identification of epithelial, mesenchymal and transitioning CTCs, and to determine DDR status on the identified CTCs, by combining the use of IF with Parsortix technology.
1
23 ...
10